Fortitude Family Office »

Immunome shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $703 60 11.72
2025-06-30 $558 60 9.30

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard S&p 500 Etf Etf (VOO)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Mid-cap Etf Etf (VO)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares U.s. Technology Etf Etf (IYW)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Immunome

FMR
T. Rowe Price Investment Management
BlackRock
Redmile Group
Vanguard Group
Point72 Asset Management
Enavate Sciences GP
Leucadia National Corporation
EcoR1 Capital
Opaleye Management
PRIMECAP Management Company
State Street Corporation
Caption Management
Toronto-Dominion Bank
Geode Capital Management

View all funds holding Immunome